See remarks
Tue, Apr 7, 2026
Apr 7
exercised or converted securities in DNA
212,949 shares @ $0.00
Decreased holdings by -50.00%
Net across this filing: +225.00% (+219,116 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).